By now, we hope you have adjusted to the usual routine and found your groove. This is a short work week, however, there is still much to do. Here are a few items to help you prepare for the day....
Merck Could Pay $700M In Schizophrenia Licensing Deal With Addex (Yahoo/AP)
Special Master Appointed In Vioxx Settlement (The Daily Advertiser)
Schering-Plough Anesthesia Drug Gets Priority Review (Reuters)
Galapagos To Collaborate With Janssen On Oncology (Reuters)
Sepracor Signs $175M Epilepsy Deal With Portugal's Bial (PharmaTimes)
Pfizer Starts Phase II Glaucoma Study In Japan (MarketWatch)
Sanofi To Pay Up to $112M To Crucell In Rabies Deal (MarketWatch)
Pfizer Cancer Drug Boosts Blood Pressure (US News/HealthDay)
AstraZeneca Seeks To Sell Extended Release Version Of Seroquel (Reuters)